These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 7477961

  • 1. Neonatal 6-hydroxydopamine lesions lead to opposing changes in the levels of dopamine receptors and their messenger RNAs.
    Frohna PA, Neal-Beliveau BS, Joyce JN.
    Neuroscience; 1995 Sep; 68(2):505-18. PubMed ID: 7477961
    [Abstract] [Full Text] [Related]

  • 2. Changes of D1 and D2 receptors in adult rat neostriatum after neonatal dopamine denervation: quantitative data from ligand binding, in situ hybridization and iontophoresis.
    Radja F, el Mansari M, Soghomonian JJ, Dewar KM, Ferron A, Reader TA, Descarries L.
    Neuroscience; 1993 Dec; 57(3):635-48. PubMed ID: 7906013
    [Abstract] [Full Text] [Related]

  • 3. There is a limited critical period for dopamine's effects on D1 receptor expression in the developing rat neostriatum.
    Thomas WS, Neal-Beliveau BS, Joyce JN.
    Brain Res Dev Brain Res; 1998 Nov 01; 111(1):99-106. PubMed ID: 9804909
    [Abstract] [Full Text] [Related]

  • 4. Ontogeny of D1A and D2 dopamine receptor subtypes in rat brain using in situ hybridization and receptor binding.
    Schambra UB, Duncan GE, Breese GR, Fornaretto MG, Caron MG, Fremeau RT.
    Neuroscience; 1994 Sep 01; 62(1):65-85. PubMed ID: 7816213
    [Abstract] [Full Text] [Related]

  • 5. Dopamine D1 receptor modulation of glutamate receptor messenger RNA levels in the neocortex and neostriatum of unilaterally 6-hydroxydopamine-lesioned rats.
    Rodríguez-Puertas R, Herrera-Marschitz M, Koistinaho J, Hökfelt T.
    Neuroscience; 1999 Mar 01; 89(3):781-97. PubMed ID: 10199613
    [Abstract] [Full Text] [Related]

  • 6. Dopamine receptors status after unilateral nigral 6-OHDA lesion. Autoradiographic and in situ hybridization study in the rat brain.
    Fornaretto MG, Caccia C, Caron MG, Fariello RG.
    Mol Chem Neuropathol; 1993 Mar 01; 19(1-2):147-62. PubMed ID: 8363701
    [Abstract] [Full Text] [Related]

  • 7. Timing: A critical determinant of the functional consequences of neonatal 6-OHDA lesions.
    Neal-Beliveau BS, Joyce JN.
    Neurotoxicol Teratol; 1999 Mar 01; 21(2):129-40. PubMed ID: 10192273
    [Abstract] [Full Text] [Related]

  • 8. Development of striatal dopaminergic function. I. Pre- and postnatal development of mRNAs and binding sites for striatal D1 (D1a) and D2 (D2a) receptors.
    Jung AB, Bennett JP.
    Brain Res Dev Brain Res; 1996 Jul 20; 94(2):109-20. PubMed ID: 8836569
    [Abstract] [Full Text] [Related]

  • 9. D1 dopamine receptor binding and mRNA levels are not altered after neonatal 6-hydroxydopamine treatment: evidence against dopamine-mediated induction of D1 dopamine receptors during postnatal development.
    Duncan GE, Breese GR, Criswell HE, Johnson KB, Schambra UB, Mueller RA, Caron MG, Fremeau RT.
    J Neurochem; 1993 Oct 20; 61(4):1255-62. PubMed ID: 8376983
    [Abstract] [Full Text] [Related]

  • 10. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
    Puschban Z, Scherfler C, Granata R, Laboyrie P, Quinn NP, Jenner P, Poewe W, Wenning GK.
    Neuroscience; 2000 Oct 20; 95(2):377-88. PubMed ID: 10658617
    [Abstract] [Full Text] [Related]

  • 11. Neonatal dopamine depletion reveals a synergistic mechanism of mRNA regulation that is mediated by dopamine(D1) and serotonin(2) receptors and is targeted to tachykinin neurons of the dorsomedial striatum.
    Campbell BM, Gresch PJ, Walker PD.
    Neuroscience; 2001 Oct 20; 105(3):671-80. PubMed ID: 11516832
    [Abstract] [Full Text] [Related]

  • 12. Temporal changes in the messenger RNA levels of cellular immediate early genes and neurotransmitter/receptor genes in the rat neostriatum and substantia nigra after acute treatment with eticlopride, a dopamine D2 receptor antagonist.
    Sirinathsinghji DJ, Schuligoi R, Heavens RP, Dixon A, Iversen SD, Hill RG.
    Neuroscience; 1994 Sep 20; 62(2):407-23. PubMed ID: 7830888
    [Abstract] [Full Text] [Related]

  • 13. The neonatal lesion of the meso-telencephalic dopaminergic pathway increases intrastriatal D2 receptor levels and synthesis and this effect is reversed by neonatal dopaminergic rich-graft.
    Mennicken F, Savasta M, Chritin M, Feuerstein C, Le Moal M, Herman JP, Abrous DN.
    Brain Res Mol Brain Res; 1995 Feb 20; 28(2):211-21. PubMed ID: 7723620
    [Abstract] [Full Text] [Related]

  • 14. Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra.
    Newman-Tancredi A, Cussac D, Brocco M, Rivet JM, Chaput C, Touzard M, Pasteau V, Millan MJ.
    Brain Res; 2001 Nov 30; 920(1-2):41-54. PubMed ID: 11716810
    [Abstract] [Full Text] [Related]

  • 15. Distribution of messenger RNAs for D1 dopamine receptors and DARPP-32 in striatum and cerebral cortex of the cynomolgus monkey: relationship to D1 dopamine receptors.
    Brené S, Hall H, Lindefors N, Karlsson P, Halldin C, Sedvall G.
    Neuroscience; 1995 Jul 30; 67(1):37-48. PubMed ID: 7477907
    [Abstract] [Full Text] [Related]

  • 16. Distribution and postnatal ontogeny of adenosine A2A receptors in rat brain: comparison with dopamine receptors.
    Johansson B, Georgiev V, Fredholm BB.
    Neuroscience; 1997 Oct 30; 80(4):1187-207. PubMed ID: 9284070
    [Abstract] [Full Text] [Related]

  • 17. The temporal evolution of striatal dopamine receptor binding and mRNA expression following hypoxia-ischemia in the neonatal rat.
    Filloux FM, Adair J, Narang N.
    Brain Res Dev Brain Res; 1996 Jun 14; 94(1):81-91. PubMed ID: 8816280
    [Abstract] [Full Text] [Related]

  • 18. Chronic blockade of muscarinic cholinergic receptors by systemic trihexyphenidyl (Artane) administration modulates but does not mediate the dopaminergic regulation of striatal prepropeptide messenger RNA expression.
    Mavridis M, Rogard M, Besson MJ.
    Neuroscience; 1995 May 14; 66(1):37-53. PubMed ID: 7637873
    [Abstract] [Full Text] [Related]

  • 19. Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanine.
    Morissette M, Goulet M, Calon F, Falardeau P, Blanchet PJ, Bédard PJ, Di Paolo T.
    Mol Pharmacol; 1996 Nov 14; 50(5):1073-9. PubMed ID: 8913337
    [Abstract] [Full Text] [Related]

  • 20. Neuropeptide messenger RNA expression in the 6-hydroxydopamine-lesioned rat striatum reinnervated by fetal dopaminergic transplants: differential effects of the grafts on preproenkephalin, preprotachykinin and prodynorphin messenger RNA levels.
    Cenci MA, Campbell K, Björklund A.
    Neuroscience; 1993 Nov 14; 57(2):275-96. PubMed ID: 8115038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.